![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Dapagliflozin and cardiovascular outcomes in type 2 diabetes (Andrea Aguilera) View |
![]() |
SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial (GPnotebook) View |
![]() |
Dapagliflozin and cardiovascular outcomes in type 2 diabetes. (Samantha Ojeda) View |
![]() |
Dapagliflozin and cardiovascular outcomes in type 2 diabetes (Damara Moncada) View |
![]() |
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes (Alli) View |
![]() |
Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors (Radcliffe Cardiology) View |
![]() |
Dapagliflozin and cardiovascular outcomes in type 2 diabetes (Miuriel Mv) View |
![]() |
Dapagliflozine and Cardiovascular Outcomes in Type 2 Diabetes (Genesis Salvador) View |
![]() |
Dapagliflozin and cardiovascular outcome in type 2 diabetes (Justin lady Vera Moreira) View |
![]() |
DAPAGLIFLOZIN AND CARDIOVASCULAR OUTCOMES IN DIABETES TYPE 2 (Roberto Guevara) View |